title: Recent developments help the defense of drug companies in 10b-5 cases.
authors.forename: A N
authors.initials: AN
authors.lastname: Salpeter
authors.forename: H
authors.initials: H
authors.lastname: Hutchins
mesh_terms: D001709:Biotechnology / Q000331:legislation & jurisprudence; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004341:Drug Evaluation; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D015507:Drugs, Investigational / Q000009:adverse effects*; D006801:Humans; D007880:Legislation, Drug; D014342:Truth Disclosure; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
chemical_list: D015507:Drugs, Investigational